GLP-1 receptor activation has revealed the cardiovascular protection [18, 19] and thus GLP-1 receptor agonist may be considered a promising new agent for the treatment of cardiovascular diseases linked to obese type 2 diabetes [20, 21]. Here, GLP1R is linked to type 2 diabetes mellitus.